Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PGR contributors: mct - updated : 22-06-2019
HGNC name progesterone receptor
HGNC id 8910
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Reproductivefemale systemuterus  highly
 female systembreastmammary gland  
 female systemovaryovarian follicle   Homo sapiens
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connective    
Epithelialbarrier/liningendometrium  
cells
SystemCellPubmedSpeciesStageRna symbol
Reproductivegranulosa cell Homo sapiens
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • zinc finger protein, class II
  • a modulating N terminal domain
  • DNA binding domain
  • a hinge region regulating the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention
  • C terminal steroid-binding domain
  • HOMOLOGY
    interspecies homolog to murine Pgr
    Homologene
    FAMILY steroid/thyroid hormone receptor superfamily
    CATEGORY transcription factor , signaling hormone , receptor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • progesterone receptor
  • PR-A acting as a transcriptional repressor
  • PR-B as an activator required for normal mammary development in the puberty
  • involved in regulation of TRPV4 expression by progesterone
  • nuclear receptor transcription factor that is essential for female fertility, in part due to its control of oocyte release from the ovary, or ovulation
  • mediates the effects of progesterone by association with a range of coregulatory proteins and binding to specific target sequences in progesterone-regulated gene promoters
  • in ovarian granulosa cells, PGR may act as an inducible coregulator for constitutively bound Sp1/Sp3 transcription factors, which are key regulators for a discrete cohort of ovulatory genes
  • CELLULAR PROCESS nucleotide, transcription
    PHYSIOLOGICAL PROCESS development , reproduction/sex
    text puberty
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • NCOA2 interacts with ESR1, ESR2 and PGR in a subtype-specific manner, which may contribute to the functional differences of these steroid receptor subtypes in brain
  • coregulator function of MAGEA11 extends to isoform-specific regulation of PGR during the cyclic development of the human endometrium
  • TNFSF11 is a direct PGR target gene and STAT5A has a novel role as a cofactor in PGR-mediated transcriptional signaling in the mammary gland
  • ARID1A positively regulates KLF15 expression with PGR to inhibit epithelial proliferation at peri-implantation
  • WBP2 acts as a transcriptional coactivator for ESR1 and progesterone receptor (PGR)
  • ovarian cycle-related Progesterone and neurosteroids regulate GABRA2 expression in the hippocampus via a non-PGR pathway, which may be relevant to menstrual-cycle related brain conditions
  • ZFHX3 is an integral transcription factor of PGR signaling in driving side-branching and alveologenesis during mammary gland development
  • cell & other
    REGULATION
    Other regulated by UBE3A (UBE3A controls mammary gland development by regulating PR-B protein turnover via the ubiquitin proteasome pathway)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    in meningioma with good prognosis
    Susceptibility to idiopathic recurrent pregnancy loss
    Variant & Polymorphism other
  • PROGINS polymorphism confers susceptibility to idiopathic recurrent pregnancy loss
  • Candidate gene
  • may be a candidate for association with preterm birth or familial preterm birth
  • Marker
    Therapy target
    ANIMAL & CELL MODELS